The global control and prevention of cervical cancer caused by HPV
The global control and prevention of cervical cancer caused by HPV
ecancermedicalscience Editor's Choice for January 2014
Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML)
Treating ALL patients with T cells targeted for CD19
Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL
Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies
T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence
Removal of alpha/beta T cells and of CD19 B cells in children With acute leukaemia
Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531
IMCPO, legal aspects of being an oncologist and the latest treatment for lung cancer in India
Childhood cancer registries in Africa
Pathology and diagnosis of nephroblastoma